Gregg Timony Email

VP, DMPK and Toxicology . Escient Pharmaceuticals

Current Roles

Employees:
60
Revenue:
$4.7M
About
We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. We are focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-inflammatory and autoreactive diseases. Based in San Diego, we are led by an experienced team of entrepreneurs with deep roots in this regionᅢᄁ¬ツᆲ¬トᄁs life sciences ecosystem and specific expertise in GPCR drug discovery and development. Escient Pharmaceuticals is supported by top-tier life-sciences investors with a proven track record for identifying and supporting successful, next-generation medicines companies.
Escient Pharmaceuticals Address
10578 Science Center Drive
San Diego, CA
United States
Escient Pharmaceuticals Email

Past Companies

Escient PharmaceuticalsVP, DMPK and Toxicology
Gossamer BioSr. Director, Preclinical Drug Safety and Disposition
Self EmployedIndependent Consultant ADME

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.